RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022
25 October 2022 - 7:05AM
(NASDAQ: RXST) RxSight, Inc., an ophthalmic
medical device company dedicated to improving the vision of
patients following cataract surgery, today announced that it will
report financial results for the third quarter 2022 after the
market close on Monday, November 7, 2022. The company’s management
will discuss the results during a conference call beginning at 1:30
p.m. Pacific Time / 4:30 p.m. Eastern Time.
Participants may register for the call here and listen through a
live and archived webcast of the event available for one year at
https://investors.rxsight.com/. While not required, it is
recommended that participants join ten minutes prior to the event
start time to ensure the necessary audio applications are
downloaded and installed. Instructions are provided (including a
dial-in option).
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery.
Additional information about RxSight can be found
at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:ir@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024